Herpes zoster in the age of focused immunosuppressive therapy.
Whitley
Richard J
RJ
Gnann
John W
JW
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D006562:Herpes Zoster / Q000453:epidemiology / Q000209:etiology*; D006801:Humans; D015994:Incidence; D051474:Neuralgia, Postherpetic / Q000453:epidemiology; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha